B

BridgeBio

Develops therapies for genetic diseases

Executive Director/Vice President Global Media Relations - Executive Communications & Comm Ops

PR & CommunicationsConfirmed live in the last 24 hours
Full-timePalo Alto, CA, USA

About the Job

Requirements

  • Experience leading media relations through corporate communications inside and outside the United States, including relationships with non-U.S. journalists and adapting messaging across multiple markets, regulatory regimes, languages, and cultural contexts.
  • Experience managing a communications-related function with direct ownership of strategy, budget, and staffing, and responsibility for managing or building a team.
  • At least 12 years of communications experience in biotechnology, pharmaceuticals, or healthcare, including significant experience supporting a publicly traded company.
  • A demonstrated track record of building senior relationships with top-tier U.S. and international reporters and securing high-impact placements for complex scientific and corporate stories.
  • Direct experience leading communications through material events such as U.S. and ex-U.S. drug approvals, clinical data readouts, regulatory milestones, earnings announcements, financings, or transactions.
  • Working knowledge of SEC disclosure requirements, Regulation FD, and the regulatory environment governing biopharmaceutical communications in the United States and abroad, as well as experience navigating the approval process.
  • Fluency with multi-market communications mechanics, including embargoes across time zones, translation and localization workflows, and in-country review requirements.
  • Exceptional editorial judgment, including setting messaging direction, improving others’ writing, and conveying complex ideas across formats, channels, and audiences.
  • Proven success as a spokesperson, media trainer, and counselor to senior executives.
  • A track record of delegating effectively and developing direct reports while retaining accountability for the function’s output.
  • Cultural fluency and judgment about when messaging should change for a market and when it should remain consistent.
  • Sound judgment, composure under pressure, and discretion in handling confidential and market-sensitive information.
  • Ability to influence without authority and lead in a fast-paced, matrixed, highly regulated environment.
  • A bachelor's degree in communications, journalism, public relations, life sciences, or a related field.

Responsibilities

  • Oversee the U.S. and ex-U.S. communications strategy end to end, setting a global narrative and directing its adaptation for each market’s media environment, regulatory regime, language, and cultural context.
  • Build and maintain senior relationships with Tier 1 press, television, and digital journalists and editors.
  • Oversee cross-border announcement execution, embargo coordination, and simultaneous multi-market releases across time zones.
  • Ensure crisis and issues frameworks account for jurisdictional differences in disclosure, product safety communication, and media norms.
  • Develop proactive and reactive media strategy aligned with corporate, pipeline, and reputational objectives, and direct teams and agencies in executing it across markets.
  • Define the company’s presence at major industry, policy, and business-of-health forums, securing speaking opportunities, media briefings, and executive positioning.
  • Serve as senior corporate media contact and cultivate high-trust relationships with priority U.S. and international journalists across national, business, financial, healthcare, science, and trade outlets.
  • Identify and secure high-stakes media opportunities, including exclusives, profiles, and complex scientific stories.
  • Own the forward-looking global catalyst and announcement calendar, sequencing news flow with Investor Relations, Clinical Development, and Regulatory.
  • Define regional earned-media, share-of-voice, sentiment, and message pull-through key performance indicators; report insights and recommendations to executive leadership regularly.
  • Advise the CEO, CFO, CSO, and other senior leaders on media engagement opportunities, risks, and trade-offs.
  • Design and deliver media training; prepare executives and scientific subject matter experts for interviews, panels, earnings calls, and high-stakes engagements in U.S. and international settings.
  • Set executive visibility strategy across bylined commentary, speaking engagements, podcasts, international conference participation, and owned channels.
  • Develop and steward an enterprise narrative that unites the company’s science, clinical progress, business strategy, and culture across markets.
  • Oversee an international team and agency network to anticipate reputational risks and lead issues management and rapid response concerning data outcomes, regulatory actions, product safety, patient access, litigation, and organizational change.
  • Partner with Human Resources and leadership to ensure employees globally are informed and prepared ahead of major external announcements.
  • Manage and develop the evolving team, set priorities, delegate clearly, give direct feedback, and grow individuals and roles as the company scales.
  • Oversee and direct U.S. and international public relations, digital, and creative agency relationships from request for proposal through the engagement lifecycle; own associated budgets and hold partners accountable for quality and return on investment.
  • Establish processes, review workflows, and approval pathways that enable a distributed team to move quickly while maintaining accuracy and compliance.

Desired Qualifications

  • Lived or worked outside the United States, either based in a non-U.S. market for a meaningful portion of a career or led a function from the United States with genuine day-to-day international accountability.
  • Deep experience with media and media training, including active spokesperson and executive coaching experience.
  • Experience managing communications staff or agencies across multiple regions, including building or restructuring an international agency network.
  • Direct experience with ex-U.S. regulatory and market milestones, including EMA, MHRA, PMDA, NMPA, or Asia-Pacific approvals; health technology assessment and reimbursement decisions; or EU and UK disclosure and promotional requirements.
  • Communications leadership at international scientific congresses and experience coordinating with U.S. congress activity.
  • Experience supporting ex-U.S. partnerships, licensing deals, or regional joint ventures, including partner-coordinated announcements.
  • Experience establishing communications in a new geography, including market entry, affiliate launch, or a first-time international listing or investor base.
  • An advanced degree in communications, business, public health, or a life sciences discipline.
  • Experience building or scaling a communications function from an early stage, including first hires, agency transitions, and bringing capabilities in-house.
  • Experience supporting a company’s transition from clinical-stage to commercial-stage operations, including product launch communications.
  • Therapeutic-area depth relevant to the company’s pipeline and fluency with the scientific publication landscape.
  • Experience partnering with Investor Relations on capital markets transactions and investor-facing communications.
  • Familiarity with patient advocacy engagement and communications considerations unique to patient communities across geographies.
  • Hands-on fluency with artificial intelligence tools and modern measurement platforms in a communications workflow.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs